These five blood and body composition markers give you the most comprehensive picture of metabolic health. All are obtainable via standard blood panels.
CGMs like Levels (Libre 3) and Hume give real-time glucose data without fingerpricks. They reveal how individual foods, exercise, sleep, and stress affect your blood sugar — data unavailable from quarterly HbA1c tests alone. We review them in our Wearables section.
| Biomarker | Optimal Range | Caution Zone | High Risk | Why It Matters |
|---|---|---|---|---|
| Fasting Glucose | <85 mg/dL | 85–99 mg/dL | ≥100 mg/dL | Predicts T2D, cardiovascular events, cognitive decline. Even high-normal fasting glucose (95–99) is associated with increased risk. |
| HbA1c | <5.3% | 5.3–5.6% | ≥5.7% | 3-month average blood glucose. Pre-diabetes begins at 5.7%. Directly predicts microvascular and macrovascular complications. |
| Fasting Insulin | <6 µIU/mL | 6–10 µIU/mL | >10 µIU/mL | The most sensitive early marker of insulin resistance — often elevated for years before fasting glucose rises. Rarely tested in routine panels. |
| Triglycerides | <80 mg/dL | 80–149 mg/dL | ≥150 mg/dL | Elevated triglycerides are a direct marker of insulin resistance and poor carbohydrate metabolism. TG/HDL ratio is a practical insulin resistance proxy. |
| Waist Circumference | Men <35", Women <31.5" | Men 35–40", Women 31.5–35" | Men >40", Women >35" | Proxy for visceral adiposity — the metabolically active fat surrounding organs that drives inflammation, insulin resistance, and cardiovascular risk. |
Ranked by strength of evidence for improving insulin sensitivity, blood glucose, and cardiometabolic risk.
Skeletal muscle is the primary site of insulin-stimulated glucose uptake. Building and maintaining muscle mass is the most durable intervention for improving insulin sensitivity.
Low-intensity aerobic training (60–70% max HR) dramatically increases mitochondrial density and fat oxidation capacity — key drivers of metabolic flexibility.
A 10-minute walk after meals blunts postprandial glucose spikes by 30–60%. One of the most accessible and effective acute glucose management tools.
Eating within a consistent 8–10 hour window appears to improve fasting glucose, insulin, and body composition independent of caloric restriction in some trials.
Even one night of poor sleep reduces insulin sensitivity by 20–25%. Chronic short sleep is a major and underappreciated driver of insulin resistance and T2D risk.
Soluble fiber slows glucose absorption and feeds beneficial gut bacteria. 25–38g/day target. Consistently associated with lower HbA1c and T2D risk in large cohorts.
Cortisol elevates blood glucose via gluconeogenesis and promotes visceral fat deposition. Chronic psychosocial stress is an independent metabolic disease risk factor.
Activates AMPK similarly to metformin. Multiple RCTs show meaningful reductions in fasting glucose, HbA1c, and triglycerides. One of the best-evidenced metabolic supplements.
Deep-dive articles on understanding and improving your metabolic health markers.
An evidence-based look at who benefits from real-time glucose data and whether CGMs like Levels and Hume change behavior and outcomes in metabolically healthy people.
Skeletal muscle is the largest insulin-sensitive tissue in the body. The dose-response relationship between muscle mass and metabolic health markers.
How low-intensity steady-state cardio rebuilds mitochondrial density, restores fat oxidation, and improves insulin sensitivity at a cellular level.
The Weizmann Institute's landmark Zeevi 2015 study showed glucose responses to identical foods vary dramatically between individuals — and the microbiome is a key driver.
Multiple RCTs show berberine reduces fasting glucose and HbA1c comparably to metformin in T2D patients. What does this mean for metabolically healthy adults?
Sleep deprivation raises cortisol, reduces GLP-1, and impairs glucose uptake. The acute and chronic mechanisms linking sleep quality to metabolic dysfunction.
The peer-reviewed evidence underpinning our metabolic health content and recommendations.
Only 12.2% of American adults met all five criteria for optimal metabolic health (blood glucose, triglycerides, HDL, blood pressure, waist circumference) — declining from 14.3% in 2000.
Among 800 participants wearing CGMs, postprandial glucose responses to identical foods varied dramatically between individuals. Gut microbiome composition was a strong predictor of response.
Meta-analysis of 41 RCTs. Resistance training significantly improved insulin sensitivity (HOMA-IR), HbA1c, and fasting glucose across diverse populations, independently of aerobic exercise.
Dose-response meta-analysis of 185 prospective studies. Highest dietary fiber intake (25–29g/day) associated with 15–30% reductions in cardiovascular events, T2D, and all-cause mortality.
Berberine activates AMPK — the same enzyme targeted by metformin — through a distinct mechanism. It improves insulin sensitivity, reduces fasting glucose, and lowers lipids in multiple RCTs.
RCT comparing time-restricted eating (8-hour window) vs. 3 structured meals in 116 adults with obesity. Weight loss was similar between groups — suggesting the meal window itself is not the primary driver.
Supplements with meaningful human clinical trial evidence for metabolic health. Affiliate disclosure →
Key questions about metabolic health, blood sugar, and insulin resistance.
VO₂ max, Zone 2 training, HRV — and how cardiovascular fitness connects directly to metabolic health.
CGMs (Levels, Hume), metabolic biomarker tracking, and smart scales for body composition monitoring.
How metabolic dysfunction accelerates the hallmarks of aging — and why metabolic health is central to longevity.